Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 2/20 | 0.36 |
| ▸ | MAOB | P27338 | 5/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8404358 | 0.77 | ADORA2A (0.45) | ADORA2AELANEMAOBGPR84CYP1A2 | |
| SCHEMBL21402593 | 0.69 | PTGS2 (0.44) | MAOB | |
| SCHEMBL11547196 | 0.68 | THRB (0.46) | ADORA2ACYP2A6 | |
| SCHEMBL16194338 | 0.67 | ALDH1A1 (0.40) | ELANEGPR84CYP1A2CYP2A6 | |
| SCHEMBL17166803 | 0.67 | CYP2A6 (0.43) | ELANECYP1A2CYP2A6 | |
| SCHEMBL11542296 | 0.66 | ADORA2A (0.43) | ADORA2AELANEMAOB | |
| SCHEMBL10558957 | 0.64 | MAPT (0.38) | CYP1A2CYP2A6 | |
| SCHEMBL24172046 | 0.64 | HSP90AA1 (0.35) | CYP1A2 | |
| SCHEMBL11405461 | 0.64 | PTGS2 (0.40) | MAOB | |
| SCHEMBL21444750 | 0.64 | CD44 (0.41) | ADORA2AMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11758803-B2 | Organometallic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-09-12 | — | — | US | disclosed |
| US-20200287144-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200287144-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | L1CAM, MSL1, EML4 | ADORA2A 4013/4885ELANE 1470/4885MAOB 1622/4885 |
| US-11758803-B2 | Organometallic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device | L1CAM, MSL1, EML4 | ADORA2A 4013/4885ELANE 1470/4885MAOB 1622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.